Publication | Closed Access

Cross-protective efficacy of the O1 Manisa + O 3039 bivalent vaccine and the O 3039 monovalent vaccine against heterologous challenge with FMDV O/Jincheon/SKR/2014 in pig

VaccinationMonovalent VaccineCross-protectionVaccine DevelopmentO 3039ImmunologyVaccine DesignPolyvalent VaccineMedicineVaccine ResearchBivalent Vaccine